66 research outputs found
Loss of Ptpn11 (Shp2) drives satellite cells into quiescence
The equilibrium between proliferation and quiescence of myogenic progenitor
and stem cells is tightly regulated to ensure appropriate skeletal muscle
growth and repair. The non-receptor tyrosine phosphatase Ptpn11 (Shp2) is an
important transducer of growth factor and cytokine signals. Here we combined
complex genetic analyses, biochemical studies and pharmacological interference
to demonstrate a central role of Ptpn11 in postnatal myogenesis of mice. Loss
of Ptpn11 drove muscle stem cells out of the proliferative and into a resting
state during muscle growth. This Ptpn11 function was observed in postnatal but
not fetal myogenic stem cells. Furthermore, muscle repair was severely
perturbed when Ptpn11 was ablated in stem cells due to a deficit in stem cell
proliferation and survival. Our data demonstrate a molecular difference in the
control of cell cycle withdrawal in fetal and postnatal myogenic stem cells,
and assign to Ptpn11 signaling a key function in satellite cell activity
KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer
<p>Abstract</p> <p>Background</p> <p>KAI1 was initially identified as a metastasis-suppressor gene in prostate cancer. It is a member of the tetraspan transmembrane superfamily (TM4SF) of membrane glycoproteins. As part of a tetraspanin-enriched microdomain (TEM), KAI1 inhibits tumor metastasis by negative regulation of Src. However, the underlying regulatory mechanism has not yet been fully elucidated. CUB-domain-containing protein 1 (CDCP1), which was previously known as tetraspanin-interacting protein in TEM, promoted metastasis via enhancement of Src activity. To better understand how KAI1 is involved in the negative regulation of Src, we here examined the function of KAI1 in CDCP1-mediated Src kinase activation and the consequences of this process, focusing on HIF-1 α and VEGF expression.</p> <p>Methods</p> <p>We used the human prostate cancer cell line PC3 which was devoid of KAI1 expression. Vector-transfected cells (PC3-GFP clone #8) and KAI1-expressing PC3 clones (PC3-KAI1 clone #5 and #6) were picked after stable transfection with KAI1 cDNA and selection in 800 <it>μ</it>g/ml G418. Protein levels were assessed by immunoblotting and VEGF reporter gene activity was measured by assaying luciferase activitiy. We followed tumor growth <it>in vivo </it>and immunohistochemistry was performed for detection of HIF-1, CDCP1, and VHL protein level.</p> <p>Results</p> <p>We demonstrated that Hypoxia-inducible factor 1α (HIF-1α) and VEGF expression were significantly inhibited by restoration of KAI1 in PC3 cells. In response to KAI1 expression, CDCP1-enhanced Src activation was down-regulated and the level of von Hippel-Lindau (VHL) protein was significantly increased. In an <it>in vivo </it>xenograft model, KAI1 inhibited the expression of CDCP1 and HIF-1α.</p> <p>Conclusions</p> <p>These novel observations may indicate that KAI1 exerts profound metastasis-suppressor activity in the tumor malignancy process via inhibition of CDCP1-mediated Src activation, followed by VHL-induced HIF-1α degradation and, ultimately, decreased VEGF expression.</p
Multiple myeloma and bone marrow mesenchymal stem cells’ crosstalk: Effect on translation initiation
Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI
Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation
- …